Evaluation of effectiveness of Kutajashtaka in the treatment of Asrigdara (Abnormal Uterine Bleeding)
Phase 2
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
- Registration Number
- CTRI/2024/05/067329
- Lead Sponsor
- Government Ayurvedic College and Hospital Patna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients willing for trial
Patients having any of the following symptoms
Excessive bleeding Per Vagina amount more than
80ml
Prolonged bleeding Per Vagina With the duration
of bleeding more than 7 days
Patients of age group 17 to 45 years
Hb equal to or greater than 8gm per dl
Exclusion Criteria
Pregnant woman
Patients having bleeding due to abortion
Ectopic Pregnancy
Any type of malignancy
Patients using IUCDs
Thyroid hormones abnormalities
Uterine and pelvic pathology like Polyps Endometrial T.B Fibroid
Adenomyosis PID
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the therapeutic efficacy and safety of Kutajashtaka in the management of AsrigdaraTimepoint: 1 month
- Secondary Outcome Measures
Name Time Method To study the ayurvedic and modern concept about asrigdaraTimepoint: 1 month